|
|
Volumn 297, Issue 14, 2007, Pages 1538-1539
|
|
Study aims to clarify efficacy, safety of eye drug treatments
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG USE;
HEALTH CARE POLICY;
HUMAN;
PREVALENCE;
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
SHORT SURVEY;
VISUAL IMPAIRMENT;
ARTICLE;
ECONOMICS;
RETINA MACULA DEGENERATION;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS;
HUMANS;
MACULAR DEGENERATION;
|
|
EID: 34247138294
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.297.14.1538 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|